NOT-CA-22-123: Notice of Pre-application Webinar for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult (RFA-CA-22-028) and Pediatric Cancers (RFA-CA-22-029), and Coordinating Center (RFA-CA-22-030)

Notice of Pre-application Webinar for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult (RFA-CA-22-028) and Pediatric Cancers (RFA-CA-22-029), and Coordinating Center (RFA-CA-22-030)

Notice Number:

NOT-CA-22-123

Key Dates

Release Date:

August 29, 2022

Related Announcements

RFA-CA-22-028: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)

RFA-CA-22-029: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)

RFA-CA-22-030: Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Wednesday, September 7, 2022 from 4:00 PM to 6:00 PM (EDT) for the Funding Opportunity Announcements (FOAs) RFA-CA-22-028 “Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)”, RFA-CA-22-029 "Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)", and RFA-CA-22-030 "Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)."

NCI staff members involved in these FOAs will provide orientation and programmatic guidance to potential applicants by explaining the goals and objectives of the Can-ACT Network and answering questions from attendees. Potential applicants are encouraged to submit their questions by September 5, 2022 via email to zhang-zhi.hu@nih.gov. Questions can also be asked spontaneously at the webinar. The webinar will be recorded and made available for those unable to attend the live event. The recording may be requested by contacting Zhang-Zhi Hu at zhang-zhi.hu@nih.gov. Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-22-028, RFA-CA-22-029, and RFA-CA-22-030.

Webinar Information

To join the webinar, pre-registration is required through WebEx at https://cbiit.webex.com/cbiit/j.php?RGID=r2f98bbe19d7ed72e93f3b7737900a3d3. The link for joining the webinar will be provided upon registration.

Webinar Date: September 7, 2022

Time: 4:00 PM to 6:00 PM EDT

Inquiries

Please direct all inquiries to:

Kasia Bourcier, Ph.D.
National Cancer Institute (NCI)
Telephone: 202-657-7589
Email: bourcierkd@nih.gov

Zhang-Zhi Hu, M.D.
National Cancer Institute (NCI)
Telephone: 202-731-8819
Email: zhang-zhi.hu@nih.gov

Anju Singh, B.V.Sc, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7603
Email: anju.singh@nih.gov